- Home
- IRON vs EXK Comparison
IRON vs EXK Comparison
Compare IRON & EXK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- EXK
- Stock Information
- Founded
- IRON 2017
- EXK 1981
- Country
- IRON United States
- EXK Canada
- Employees
- IRON N/A
- EXK N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- EXK Precious Metals
- Sector
- IRON Health Care
- EXK Basic Materials
- Exchange
- IRON Nasdaq
- EXK Nasdaq
- Market Cap
- IRON 2.1B
- EXK 1.7B
- IPO Year
- IRON N/A
- EXK N/A
- Fundamental
- Price
- IRON $85.63
- EXK $8.05
- Analyst Decision
- IRON Strong Buy
- EXK Strong Buy
- Analyst Count
- IRON 13
- EXK 4
- Target Price
- IRON $102.23
- EXK $8.69
- AVG Volume (30 Days)
- IRON 623.6K
- EXK 18.0M
- Earning Date
- IRON 11-11-2025
- EXK 11-07-2025
- Dividend Yield
- IRON N/A
- EXK N/A
- EPS Growth
- IRON N/A
- EXK N/A
- EPS
- IRON N/A
- EXK N/A
- Revenue
- IRON N/A
- EXK $247,749,000.00
- Revenue This Year
- IRON N/A
- EXK $91.50
- Revenue Next Year
- IRON N/A
- EXK $64.53
- P/E Ratio
- IRON N/A
- EXK N/A
- Revenue Growth
- IRON N/A
- EXK 11.64
- 52 Week Low
- IRON $30.82
- EXK $2.95
- 52 Week High
- IRON $95.95
- EXK $10.37
- Technical
- Relative Strength Index (RSI)
- IRON 69.02
- EXK 51.46
- Support Level
- IRON $83.52
- EXK $7.67
- Resistance Level
- IRON $89.00
- EXK $8.32
- Average True Range (ATR)
- IRON 3.84
- EXK 0.66
- MACD
- IRON 1.08
- EXK -0.14
- Stochastic Oscillator
- IRON 64.05
- EXK 22.35
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About EXK Endeavour Silver Corporation (Canada)
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has two operating mining segments which are located in Mexico, Guanacevi and Bolanitos. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.